Literature DB >> 12634869

Carrier frequency of the V377I (1129G>A) MVK mutation, associated with Hyper-IgD and periodic fever syndrome, in the Netherlands.

Sander M Houten1, Christiaan S van Woerden, Frits A Wijburg, Ronald J A Wanders, Hans R Waterham.   

Abstract

Hyper-IgD and periodic fever syndrome (HIDS) and mevalonic aciduria (MA) are two autosomal recessive disorders that both are caused by a deficient activity of the enzyme mevalonate kinase (MK) due to mutations in the encoding gene (MVK). The most frequently occurring MVK mutation, V377I (1129G>A), has been identified exclusively in HIDS patients. Other common mutations have been associated with both HIDS and MA. To estimate the incidence of MK deficiency in the Netherlands, we determined the carrier frequency of the V377I mutation in genomic DNA extracted from anonymised newborn screening cards by PCR-RFLP. We found 14 carriers among 2138 analysed samples (1 : 153). Based on the V377I allele frequency of 42% in patients diagnosed with MK deficiency, the carrier frequency of any MVK mutation in the Dutch population can be calculated as 1 : 65. This predicts a disease incidence between 1 in 5196 and 1 in 53 656, which is far more than actually observed. Although under-diagnosis of patients with MK deficiency remains possible, this discrepancy probably is due to a reduced penetrance of V377I homozygosity. Analysis of the distribution of the V377I allele within patients carrying MVK mutations revealed that this was not according to the Hardy-Weinberg equilibrium principle, most probably due to an under-representation of V377I homozygotes in HIDS. Homozygotes for V377I might exhibit a much milder phenotype of MK deficiency or no disease-phenotype at all.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634869     DOI: 10.1038/sj.ejhg.5200933

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

1.  Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.

Authors:  Donato Rigante; Valentina Ansuini; Barbara Bertoni; Anna Lisa Pugliese; Laura Avallone; Gilda Federico; Achille Stabile
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

2.  Intermittent neutropenia as an early feature of mild mevalonate kinase deficiency.

Authors:  Nima Parvaneh; Vahid Ziaee; Mohammad-Hassan Moradinejad; Isabelle Touitou
Journal:  J Clin Immunol       Date:  2013-11-01       Impact factor: 8.317

Review 3.  Genetics of monogenic autoinflammatory diseases: past successes, future challenges.

Authors:  Ivona Aksentijevich; Daniel L Kastner
Journal:  Nat Rev Rheumatol       Date:  2011-07-05       Impact factor: 20.543

4.  Evolution. Systematic humanization of yeast genes reveals conserved functions and genetic modularity.

Authors:  Aashiq H Kachroo; Jon M Laurent; Christopher M Yellman; Austin G Meyer; Claus O Wilke; Edward M Marcotte
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

Review 5.  Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Oskar Schnappauf
Journal:  Nat Rev Rheumatol       Date:  2021-05-25       Impact factor: 20.543

Review 6.  Clinical immunology review series: An approach to the patient with a periodic fever syndrome.

Authors:  H J Lachmann
Journal:  Clin Exp Immunol       Date:  2011-07-07       Impact factor: 4.330

Review 7.  [Hereditary periodic fever].

Authors:  P Lamprecht; C Timmann; K Ahmadi-Simab; W L Gross
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

8.  [Molecular diagnostics of hereditary fever syndromes. Familial Mediterranean fever (FMF), hyperimmunoglobulin D syndrome (HIDS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndrome (CAPS: FCAS, MWS, NOMID/CINCA)].

Authors:  C Timmann; R Horstmann
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 9.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

10.  Developments in the scientific and clinical understanding of autoinflammatory disorders.

Authors:  Helen J Lachmann; Philip N Hawkins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.